Center gets SC notice on PIL seeking disclosure of COVID vaccine trial data

While hearing the plea, the bench referred to the problem of "vaccine hesitancy" in the country and asked advocate Prashant Bhushan, who was appearing for the petitioner, as to whether entertaining the petition would not create doubt in the minds of the citizens over vaccines.

Published On 2021-08-09 04:00 GMT   |   Update On 2021-08-09 13:15 GMT

New Delhi: The Supreme Court on Monday sought responses from the Centre and others on a plea seeking directions for disclosure of data regarding clinical trials of COVID-19 vaccines.

A bench of justices L Nageswara Rao and Hrishikesh Roy issued notice on the plea, and asked the Centre and others to respond to it within four weeks.

While hearing the plea, the bench referred to the problem of "vaccine hesitancy" in the country and asked advocate Prashant Bhushan, who was appearing for the petitioner, as to whether entertaining the petition would not create doubt in the minds of the citizens over vaccines.

While making it clear that neither it is an "anti-vaccine petition" nor the petitioner is seeking to stop Covid vaccination in the country, Bhushan said transparency on the issue was needed and disclosure of data would rather clear all the doubts.

The bench was hearing a plea seeking directions for disclosure of data on clinical trials of COVID-19 vaccines and also on post vaccination.

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News